12 Best Medical Device Stocks to Buy According to Analysts

Page 7 of 11

5. Delcath Systems, Inc. (NASDAQ:DCTH)

Analyst Upside: 139.76%

Number of Hedge Fund Holders: 32

Delcath Systems, Inc. (NASDAQ:DCTH) is one of the best medical device stocks to buy according to analysts. On August 6, H.C. Wainwright analyst Swayampakula Ramakanth maintained a bullish stance on Delcath Systems, Inc. (NASDAQ:DCTH), giving the stock a Buy rating and raising the price target from $29 to $31.

The analyst based the rating upgrade on the solid adoption and performance of Delcath Systems, Inc.’s (NASDAQ:DCTH) HEPZATO product, as the company experienced a notable revenue growth in Q2, primarily attributed to HEPZATO’s sales, which underwent a significant year-over-year increase.

The analyst reasoned that the activation of several treatment centers and plans for further expansion supported this growth, suggesting a solid market presence and considerable potential for continued revenue growth.

Delcath Systems, Inc. (NASDAQ:DCTH) is a specialty pharmaceutical and medical devices company that engages in the treatment of primary and metastatic liver cancers. The company’s products include CHEMOSAT and HEPZATO.

Page 7 of 11